Affiliation: University of Sydney
- Consumer impact of an interactive decision aid for rectal cancer patients offered adjuvant therapyP N Butow
Surgical Outcomes Research Centre SOURCE, University of Syndey, NSW, Australia
Colorectal Dis 8:676-82. 2006....
- What drives health-care spending priorities? An international survey of health-care professionalsGlenn Salkeld
School of Public Health, University of Sydney, Sydney, Australia
PLoS Med 4:e94. 2007
- Evidence-based consumer choice: a case study in colorectal cancer screeningGlenn Salkeld
Screening Test Evaluation Program, School of Public Health, Surgical Outcomes Research Centre, University of Sydney, A27, NSW 2006
Aust N Z J Public Health 27:449-55. 2003..To provide policymakers with information that would assist them in designing the future national screening program...
- A matter of trust--patient's views on decision-making in colorectal cancerGlenn Salkeld
School of Public Health and Surgical Outcomes Research Centre SOuRCe, Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW, Australia
Health Expect 7:104-14. 2004..To determine which aspects of the treatment decision process, therapy and outcomes are most important to patients with colorectal cancer (CRC)...
- What constitutes success in preventive health care? A case study in assessing the benefits of hip protectorsG Salkeld
Screening Test Evaluation Program STEP, School of Public Health, A27, Social, Public Health Economics Research Group, University of Sydney, NSW 2006, Australia
Soc Sci Med 59:1593-601. 2004..In this context, success might be viewed as maximising the opportunity for individuals to make an informed choice...
- Discrete-choice experiment to measure patient preferences for the surgical management of colorectal cancerG Salkeld
School of Public Health, Surgical Outcomes Research Centre, University of Sydney, New South Wales, Australia
Br J Surg 92:742-7. 2005..Establishing trust between a patient and his or her surgeon is of paramount importance. The aim of this study was to assess the relative importance of the 'attributes of trust' between surgeon and patient with colorectal cancer...
- Patient and physician preferences for surgical and adjuvant treatment options for rectal cancerJames D Harrison
BSc Hons, Surgical Outcomes Research Centre, Royal Prince Alfred Hospital, PO Box M157, Missenden Road, Sydney, New South Wales, Australia 2050
Arch Surg 143:389-94. 2008..Patients and their clinicians hold varying preferences for surgical and adjuvant treatment therapies for rectal cancer...
- Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancerKirsten Howard
Screening and Test Evaluation Program STEP, School of Public Health, University of Sydney, Sydney, NSW, Australia
Value Health 12:354-63. 2009....
- Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysisKirsten Howard
School of Public Health, University of Sydney, and The Royal Prince Alfred Hospital, Sydney, NSW, Australia
Value Health 13:196-208. 2010..We therefore sought to estimate the costs and health outcomes of alternative strategies to prevent end-stage kidney disease, compared with usual care...
- Preferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: a discrete choice experimentKirsten Howard
Sydney School of Public Health, University of Sydney, Sydney, Australia
Value Health 14:1146-52. 2011..The aim of this study was to determine test characteristics important to patients and to examine trade-offs in attributes that patients are willing to accept in the context of the diagnosis of colorectal cancer...
- Implementing patient decision support tools: moving beyond academia?James D Harrison
Surgical Outcomes Research Centre, Sydney South West Area Health Service and School of Public Health, University of Sydney, Sydney, NSW, Australia
Patient Educ Couns 76:120-5. 2009..To ascertain the feasibility of implementing three decision support tools (DSTs) for people with rectal cancer within the surgical consultation...
- Surgical and oncology trials for rectal cancer: who will participate?James D Harrison
Surgical Outcomes Research Centre, Sydney South West Area Health Service and University of Sydney, Sydney, Australia
Surgery 142:94-101. 2007..Furthermore, understanding why patients are unwilling to enter RCTs is imperative before the current trend of low participation can be reversed...
- Measuring patient preference and surgeon choiceJane M Young
Surgical Outcomes Research Centre, University of Sydney and Royal Prince Albert Hospital, Sydney, Australia
Surgery 143:582-8. 2008..We also present a simple method to measure individual and community equipoise among expert clinicians to assess the feasibility of future randomized trials in surgery...
- Enhancing citizen engagement in cancer screening through deliberative democracyLucie Rychetnik
Screening and Test Evaluation Program, Room 301F, Level 3, Edward Ford Building A27, School of Public Health, University of Sydney, NSW 2006, Australia
J Natl Cancer Inst 105:380-6. 2013..Policies that take account of citizens' opinions through a deliberative democracy process can be considered more legitimate, justifiable, and feasible than those that don't...
- How do people with chronic kidney disease value cancer-related quality of life?Germaine Wong
Centre for Kidney Research, The Children s Hospital at Westmead, School of Public Health, Sydney University, New South Wales, Australia
Nephrology (Carlton) 17:32-41. 2012..To estimate the utility-based quality of life (QOL) of people with chronic kidney disease (CKD) and to estimate the QOL associated with two hypothetical colorectal cancer health states...
- Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screeningMichelle Cunich
Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia
Patient 4:153-62. 2011..Given the uncertainty surrounding the trade offs between benefits and harms for prostate cancer screening, this topic was chosen as the vehicle to introduce this new decision-support template...
- High participation rates are not necessary for cost-effective colorectal cancer screeningKirsten Howard
Health Economics, Screening and Test Evaluation Program STEP, School of Public Health, Edward Ford Building A27, University of Sydney, Australia
J Med Screen 12:96-102. 2005....
- HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?Kirsten Howard
Screening and Test Evaluation Program, School of Public Health, University of Sydney, Sydney, NSW, Australia
Health Econ 17:593-605. 2008..A modelled application of trial-based data will allow characterisation of the true population costs, benefits, risks and harms of alternative triage strategies and subsequent policy implications thereof...
- Validity, responsiveness, and minimal important difference for the SF-6D health utility scale in a spinal cord injured populationBonsan Bonne Lee
Prince of Wales Spinal Unit, Prince of Wales Hospital, Sydney, NSW, Australia
Value Health 11:680-8. 2008..To determine the feasibility, acceptability, discriminative validity, responsiveness, and minimal important difference (MID) of the SF-6D for people with spinal cord injury (SCI)...
- The cost effectiveness of screening for genital Chlamydia trachomatis infection in AustraliaSilke Walleser
NHMRC Clinical Trials Centre, University of Sydney, NSW 2050, Australia
Sex Health 3:225-34. 2006....
- Informed choice for screening: implications for evaluationLes Irwig
Screening and Test Evaluation Program, School of Public Health, Edward Ford Building, A27, University of Sydney, NSW 2006, Australia
BMJ 332:1148-50. 2006
- Are cancer drugs less likely to be recommended for listing by the Pharmaceutical Benefits Advisory Committee in Australia?Lesley Chim
Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia
Pharmacoeconomics 28:463-75. 2010..There is concern that the cost-effectiveness hurdle will limit access to new cancer treatments because of their high costs and modest benefits...
- Media influence on Herceptin subsidization in Australia: application of the rule of rescue?Ross MacKenzie
School of Public Health, University of Sydney 2006, Australia
J R Soc Med 101:305-12. 2008..The cost to the government would be A$470 million over three years for treatment of an estimated 2100 women annually...
- Is it worth the risk? A systematic review of instruments that measure risk propensity for use in the health settingJames D Harrison
Surgical Outcomes Research Centre SOURCE, Central Sydney Area Health Service and the University of Sydney, P O Box M157, Missenden Rd, NSW 2050, Australia
Soc Sci Med 60:1385-96. 2005..The further adaptation and validation of these instruments among older adults are important avenues for future research...
- The cost-effectiveness of increasing kidney transplantation and home-based dialysisKirsten Howard
University of Sydney, Australia
Nephrology (Carlton) 14:123-32. 2009..We aimed to quantify these implications for increasing kidney transplantation and improving the rate of home-based dialysis...
- An economic perspective on evidence-based patient choice in surgeryGlenn Salkeld
Surgical Outcomes Research Centre, School of Public Health, University of Sydney, Sydney, New South Wales, Australia
ANZ J Surg 73:427-30. 2003..We hope that this paper will provoke discussion on the concept of EBPC and cost-effectiveness analysis in surgical decision-making...
- Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian studyMarianne F Weber
Cancer Research Division, Cancer Council NSW, PO Box 572, Kings Cross, Sydney, NSW 1340, Australia
BMC Public Health 13:429. 2013..We examined sociodemographic and health-related factors associated with the use of these tests in the previous two years either alone or in combination...
- Getting evidence into policy: The need for deliberative strategies?Kathy Flitcroft
Screening and Test Evaluation Program, Sydney School of Public Health, University of Sydney, Edward Ford Building, A27 Fisher Road, Sydney, NSW 2006, Australia
Soc Sci Med 72:1039-46. 2011..Such deliberative models could help overcome the limitations on the use of evidence by embedding public review of evidence as the first step in the institutional decision-making processes...
- Model of outcomes of screening mammography: information to support informed choicesAlexandra Barratt
Screening and Test Evaluation Program, School of Public Health, University of Sydney, NSW 2006, Australia
BMJ 330:936. 2005..To provide easy to use estimates of the benefits and harms of biennial screening mammography for women aged 40, 50, 60, and 70 years...
- Communicating about screeningVikki A Entwistle
Social Dimensions of Health Institute, University of Dundee, UK
BMJ 337:a1591. 2008
- Is home screening for bowel cancer a good idea?Barbara Ann Adelstein
Aust N Z J Public Health 27:265-6. 2003
- An evidence-based specialist breast nurse role in practice: a multicentre implementation studyBarbara Liebert
National Breast Cancer Centre, PO Box 572, Kings Cross, NSW 1340, Australia
Eur J Cancer Care (Engl) 12:91-7. 2003..In conclusion, the SBN model is feasible and acceptable within diverse Australian treatment centres; there is evidence that some aspects of care were improved by the SBN...